Colorectal Cancer Trial, Recruiting NCT05612347 Sponsor: Dartmouth-Hitchcock Medical Center Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT05612347
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who speak English or Spanish
  • People who have a personal history of colorectal polyps (growths found in the large intestine)
  • People whose most recent colonoscopy found 2 or fewer polyps that were not classified as advanced
  • People who are currently due, or will be due within the next 12 months, for a colonoscopy
  • People who are able to sign a written consent form agreeing to take part

Who may not be able to join:

  • People who have a personal history of colorectal (bowel) cancer
  • People who have a known genetic condition that significantly raises the risk of bowel cancer, such as Lynch Syndrome, Familial Adenomatous Polyposis (FAP), or Serrated Polyposis Syndrome
  • People who have a personal history of inflammatory bowel disease, such as ulcerative colitis or Crohn's disease
  • People whose most recent colonoscopy found one or more advanced polyps, or 3 or more non-advanced polyps
  • People whose overall health may mean that routine polyp monitoring is unlikely to benefit them — for example, those with recent heart treatment within the last 6 months, heart failure affecting daily function, lung disease requiring home oxygen, a stroke within the last 4 months, dementia affecting day-to-day activities, severe liver disease requiring certain medications, severe kidney disease requiring dialysis, or a new cancer diagnosis within the past year (confirm with trial site)
  • People who are not able to sign a written consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Audrey H Calderwood, MD, MS, Dartmouth-Hitchcock Medical Center

Phone: 857-4987233

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 June 2023
Est. completion
31 May 2030

Where this trial is recruiting

🇨🇦 Canada 🇺🇸 United States

Primary endpoints

Incidence of advanced neoplasia in each study group, annual FIT and colonoscopy, assessed by comparing the detection of advanced neoplasia between the two study groups.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov